Trial Condition(s):

Hyperkinetic Syndrome

Effects of Lisuride and placebo in hyperkinetic children

Bayer Identifier:

Trial_EXC009

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
54
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Dopergin (Lisuride Hydrogen-Maleate, BAYR5936)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information